Peptide Characterization

Introduction: Immunogenicity Risk Assessment of Peptide Impurities is a key part of pharmaceutical development whenever an unexpected impurity appears in […]

Introduction: Peptide Synthesis vs Protein Manufacturing is an important distinction in pharmaceutical development, biotechnology, and analytical science, and the two

Introduction Peptide Analytical Method Development and Validation is a critical component of peptide drug development because peptide molecules present analytical

Introduction The comprehensive implementation of Oral Peptide Drug Product Characterization requires an integrated assessment of intestinal permeation enhancers, enzymatic degradation

Introduction Characterizing Peptides in PLGA Microsphere and Depot Formulations requires sophisticated orthogonal analytical methodologies to assess complex drug release kinetics,

Introduction The Immunogenicity Risk Assessment of Peptide Impurities represents a critical regulatory evaluation framework established by the U.S. Food and

Introduction: MALDI-TOF mass spectrometry for peptide characterization is widely used to determine peptide molecular mass, support identity confirmation, and evaluate

Introduction PEGylated Peptide Characterization represents a comprehensive analytical framework designed to assess batch-to-batch consistency, chemical integrity, structural conformation, and purity

Introduction Non-enzymatic Deamidation and Aspartate Isomerization in Therapeutic Peptides are significant chemical degradation pathways that can modify peptide backbone structure,

Introduction Ion Mobility Mass Spectrometry enables the resolution of co-eluting isomeric peptide impurities by distinguishing gas-phase peptide ions according to